GB201616880D0 - Compound for use in medicine - Google Patents

Compound for use in medicine

Info

Publication number
GB201616880D0
GB201616880D0 GBGB1616880.9A GB201616880A GB201616880D0 GB 201616880 D0 GB201616880 D0 GB 201616880D0 GB 201616880 A GB201616880 A GB 201616880A GB 201616880 D0 GB201616880 D0 GB 201616880D0
Authority
GB
United Kingdom
Prior art keywords
medicine
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
GBGB1616880.9A
Other versions
GB2554703A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Bradford
Original Assignee
University of Bradford
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Bradford filed Critical University of Bradford
Priority to GB1616880.9A priority Critical patent/GB2554703A/en
Publication of GB201616880D0 publication Critical patent/GB201616880D0/en
Priority to PCT/GB2017/053009 priority patent/WO2018065771A1/en
Publication of GB2554703A publication Critical patent/GB2554703A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/513—Organic macromolecular compounds; Dendrimers
    • A61K9/5146—Organic macromolecular compounds; Dendrimers obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyamines, polyanhydrides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/513—Organic macromolecular compounds; Dendrimers
    • A61K9/5146—Organic macromolecular compounds; Dendrimers obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyamines, polyanhydrides
    • A61K9/5153—Polyesters, e.g. poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
GB1616880.9A 2016-10-05 2016-10-05 Compound for use in medicine Withdrawn GB2554703A (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GB1616880.9A GB2554703A (en) 2016-10-05 2016-10-05 Compound for use in medicine
PCT/GB2017/053009 WO2018065771A1 (en) 2016-10-05 2017-10-05 Inhibitor of ran at transcriptional level for use in the treatment of cancer

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB1616880.9A GB2554703A (en) 2016-10-05 2016-10-05 Compound for use in medicine

Publications (2)

Publication Number Publication Date
GB201616880D0 true GB201616880D0 (en) 2016-11-16
GB2554703A GB2554703A (en) 2018-04-11

Family

ID=57571218

Family Applications (1)

Application Number Title Priority Date Filing Date
GB1616880.9A Withdrawn GB2554703A (en) 2016-10-05 2016-10-05 Compound for use in medicine

Country Status (1)

Country Link
GB (1) GB2554703A (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201915598D0 (en) * 2019-10-28 2019-12-11 Univ Bradford Methods for determining the invasive and/or metastic potential of a tumour

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2017031059A (en) * 2014-01-29 2017-02-09 学校法人慶應義塾 Cancer stem cell growth inhibitor and intracellular active oxygen accumulation inducer
EP2932969A1 (en) * 2014-04-17 2015-10-21 Deutsches Krebsforschungszentrum Stiftung des Öffentlichen Rechts Pancreatic cancer therapy and diagnosis

Also Published As

Publication number Publication date
GB2554703A (en) 2018-04-11

Similar Documents

Publication Publication Date Title
HK1244000B (en) Polycyclic-carbamoylpyridone compounds and their pharmaceutical use
HK1249103B (en) Polycyclic-carbamoylpyridone compounds and their pharmaceutical use
IL248767B (en) Trimethoxyphenyl-benzimidazole compound for use in the treatment of cancer
GB201701400D0 (en) Compound for use in medicine
ZA201701492B (en) Pyrazolothiazole compound and medicine
IL250160A0 (en) Pharmaceutical agent
SG11201608123VA (en) Pharmaceutical composition for external use
GB201406115D0 (en) New pharmaceutical use
GB201616880D0 (en) Compound for use in medicine
GB201517133D0 (en) New pharmaceutical use
SG11201608124XA (en) Pharmaceutical composition for external use
GB201409662D0 (en) New pharmaceutical use
GB201701388D0 (en) Compound for use in medicine
GB201616767D0 (en) New pharmaceutical use
GB201601991D0 (en) Medicine
GB201517454D0 (en) New pharmaceutical use
GB201517132D0 (en) New pharmaceutical use
SG11201608122PA (en) Pharmaceutical composition for external use
GB201508613D0 (en) New pharmaceutical use
GB201508611D0 (en) New pharmaceutical use
GB201507813D0 (en) New pharmaceutical use
GB201406154D0 (en) Pharmaceutical compound
GB201402341D0 (en) Pharmaceutical compound

Legal Events

Date Code Title Description
WAP Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1)